Search bioRxiv⌕ Search

Biology subjects

Brahmachari, S. K.

Publications and source records attributed to Brahmachari, S. K..

4 recordsLinked to original sources

Invariant Genes in Human Genomes

With large-scale human genome and exome sequencing, a lot of focus has gone in studying variations present in genomes and their associations to various diseases. Since major emphasis has been put on their variations, less focus has been given to invariant genes in the population. Here we present 60,706 genomes from the ExAC database to identify population specific invariant genes. Out of 1,336 total genes drawn from various population specific invariant genes, 423 were identified to be mostly (allele frequency less than 0.001) invariant across different populations. 46 of these invariant genes showed absolute invariance in all populations. Most of these common invariant genes have homologs in primates, rodents and placental mammals while 8 of them were unique to human genome and 3 genes still had unknown functions. Surprisingly, a majority were found to be X-linked and around 50% of these genes were not expressed in any tissues. The functional analysis showed that the invariant genes are not only involved in fundamental functions like transcription and translation but also in various developmental processes. The variations in many of these invariant genes were found to be associated with cancer, developmental diseases and dominant genetic disorders.

genomics↗

Spatio-Temporal Network Dynamics of Genes Underlying Schizophrenia

Schizophrenia (SZ) is a debilitating mental illness with multigenic etiology and high heritability. Despite extensive genetic studies the molecular etiology stays enigmatic. A systems biology study had suggested a protein-protein interaction (PPI) network for SZ with 504 novel PPIs amongst which several genes happen to be drug targets of existing FDA approved drugs. Although the PPI network presented all possible pairs of interactions (known and novel), it lacks a spatio-temporal information. The onset of psychiatric disorders is predominantly in adolescent and young adult stages, often accompanied by subtle structural abnormalities in multiple regions of the brain. Hence, there is a need to redefine the generic PPI network as a function of time (developmental stages) and space (brain regions). The availability of BrainSpan atlas data allowed us to redefine the SZ interactome as a function of space and time. The absence of non-synonymous variants in centenarians and non-psychiatric ExAC database allowed us to identify the variants of criticality. The expression of candidate genes in different brain regions and during developmental stages, responsible for cognitive processes as well as the onset of disease were studied. A subset of novel interactors detected in the network was further validated using gene-expression data of psychiatric postmortem brains. From the long list of drug targets proposed from the interactome study and based on the microarray gene-expression results, we have shortlisted a probable subset of 10 drug targets (targeted by 34 FDA approved drugs) coalescing into 81 biological pathways, that could be potentially repurposed for neuropsychiatric disorders.

bioinformatics↗

Intronic non-coding RNAs within ribosomal protein coding genes can regulate biogenesis of yeast ribosome

The genome of the budding yeast (Saccharomyces cerevisiae) has selectively retained introns in ribosomal protein coding genes. The function of these introns has remained elusive in spite of experimental evidence that they are required for the fitness of yeast. Here, we computationally predict novel small RNAs that arise from the intronic regions of ribosomal protein (RP) coding genes in Saccharomyces cerevisiae. Further, we experimentally validated the presence of seven intronic small RNAs (isRNAs). Computational predictions suggest that these isRNAs potentially bind to the ribosomal DNA (rDNA) locus or the corresponding rRNAs. Several isRNA candidates can also interact with transcripts of transcription factors and small nucleolar RNAs (snoRNAs) involved in the regulation of rRNA expression. We propose that the isRNAs derived from intronic regions of ribosomal protein coding genes may regulate the biogenesis of the ribosome through a feed-forward loop, ensuring the coordinated regulation of the RNA and protein components of the ribosomal machinery. Ribosome biogenesis and activity are fine-tuned to the conditions in the cell by integrating nutritional signals, stress response and growth to ensure optimal fitness. The enigmatic introns of ribosomal proteins may prove to be a novel and vital link in this regulatory balancing act.

bioinformatics↗

Intronic miRNA Mediated Gene Expression Regulation Controls Protein Crowding Inside the Cell

SUMMARYGene regulatory effects of microRNAs at a posttranscriptional level has been established over the last decade. In this study, we analyze the interaction networks of mRNA translation regulation through intronic miRNA, under various tissue-specific cellular contexts, taking into account the thermodynamic affinity, kinetics, and the presence of competitive interactors. This database, and analysis has been made available through an open-access web-server, miRiam, to promote further exploration.\n\nHere we report that expression of genes involved in Apoptosis Processes, Immune System Processes, Translation Regulator Activities, and Molecular Transport Activities within the cell are predominately regulated by miRNA mediation. Our findings further indicate that this regulatory effect has a profound effect in controlling protein crowding inside the cell. A miRNA mediated gene expression regulation serves as a temporal regulator, allowing the cellular machinery to temporarily pause the translation of mRNA, indicating that the miRNA-mRNA interactions may be important for governing the optimal usage of cell volume.

bioinformatics↗